
    
      To compare the recurrence rate 24 weeks after ablative therapy in subjects with external
      genital warts trated with imiquimod, 3 applications per week for 4 weeks followed by ablative
      therapy versus vehicle, 3 applications per week for 4 weeks followed by ablative therapy. A
      recurrence is defined as the investoigator-assessed occurrence of lesion(s) within the
      baseline area cleared by the treatment: imiquimod/vehicle then ablative therapy (either the
      initial ablative ther√°py session (A0), or if required for complete clearance of baseline
      lesions, a second ablative therapy session (A2).
    
  